[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351157-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351157-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comparison-of-clinical-performance-between-digital-breast-tomosynthesis-and-mammous-n","Comparison of Clinical Performance Between Digital Breast Tomosynthesis and MammouS-N","","Background/Objectives: Compare lesion visibility for breast cancer between a newly developed standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and identify factors influencing visibility. Methods: Prospectively enrolled 100 women with biopsy-confirmed breast cancer scheduled for DBT (Jan–Jul 2024); both DBT and ultrasound were performed same day. Two radiologists scored lesion visibility (0–5) with Wilcoxon signed-rank testing. Results: MammouS-N showed higher scores for one reviewer and no significant difference for the other; noncalcified lesions obscured on DBT were better visualized on MammouS-N. Conclusions: MammouS-N complements DBT, especially for dense-breast non-calcified lesions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comparison-of-clinical-performance-between-digital-breast-tomosynthesis-and-mammous-n/351157/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comparison-of-clinical-performance-between-digital-breast-tomosynthesis-and-mammous-n/351157.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of comparing MammouS-N with DBT?","Question",{"text":63,"@type":64},"To compare visibility of breast cancer lesions between the standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and to determine factors affecting lesion visibility.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was lesion visibility evaluated in the study?",{"text":68,"@type":64},"Two radiologists independently assigned visibility scores (0–5) to lesions corresponding to biopsy-confirmed breast cancers identified using magnetic resonance imaging.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show for non-calcified lesions?",{"text":72,"@type":64},"Noncalcified lesions that were obscured on DBT were better visualized on MammouS-N (p \u003C 0.001) by both reviewers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351157,1790277044,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Article  \nComparison of Clinical Performance Between Digital Breast Tomosynthesis and MammouS-N  \nSung Ui Shin 1, Mijung Jang 1, Bo La Yun 1, Su Min Cho 1, Yoon Yeong Choi 1, Bohyoung Kim 2, Min Jung Kim 3 and Sun Mi Kim 1, *  \nAcademic Editor: Emilio Quaia  \nReceived: 24 December 2025  \nRevised: 17 January 2026  \nAccepted: 22 January 2026  \nPublished: 30 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si 13620, Gyeonggi-do, Republic of Korea; [shinsungui@gmail.com](shinsungui@gmail.com) (S.U.S.); [mjjang74@gmail.com](mjjang74@gmail.com) (M.J.); [y2choi822@gmail.com](y2choi822@gmail.com) (Y.Y.C.)  \n2 Department of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin-si 17035, Gyeonggi-do, Republic of Korea  \n3 Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul 03722, Republic of Korea  \n* Correspondence: [kimsmlms@daum.net](kimsmlms@daum.net); Tel.: +82-31-787-7609  \nSimple Summary  \nDense breast tissue complicates breast cancer detection using mammography alone. This study compared digital breast tomosynthesis with a novel standing automated breast ultrasound system in women with biopsy-confirmed breast cancer. Tomosynthesis effectively detected calcified lesions, while ultrasound provided superior visualization of non-calcified lesions without radiation exposure. The ultrasound system offers automated and reproducible imaging that integrates seamlessly into existing workflows, making it a valuable complement to tomosynthesis, especially for women with dense breasts. These findings support further studies on combined imaging approaches to improve breast cancer screening and diagnosis.  \nAbstract  \nBackground/Objectives: We compared the visibility of breast cancer using the newly developed standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and identified factors influencing lesion visibility. Methods: We prospectively enrolled 100 women (mean age: 51.6 years; range: 26–76 years) who were diagnosed with breast cancer and were scheduled to undergo DBT between January and July 2024 . They underwent DBT and an ultrasound on the same day. Two radiologists evaluated the visibility scores (0–5) of lesions corresponding to biopsy-confirmed breast cancers identified using magnetic resonance imaging. The Wilcoxon signed-rank test was used to compare the visibility scores of cancers identified on DBT and/or MammouS-N images. Results: Among the 100 women, invasive ductal carcinoma was the most common malignancy (73%) . DBT findings included negative findings (7%), masses (46%), masses with calcification (29%), calcifications only (15%), and architectural distortions (3%) . On MammouS-N ultrasound, most lesions were classified as masses (93%), whereas 7% were non-mass lesions. For Reviewer 1, MammouS-N demonstrated significantly higher visibility scores (higher scores: 26 on MammouS-N, seven on DBT; equal scores: 67, z = −3.234, p = 0.001) . For Reviewer 2, the two modalities showed no significant difference in visibility (higher scores: 27 on MammouS-N, 28 on DBT, equal scores: 45, z = −0.040, p = 0.968) . Noncalcified lesions that were obscured on DBT were better visualized on MammouS-N (p \u003C 0.001) by both reviewers. Conclusions: MammouS-N holds promise as an imaging modality complementary to DBT in women with dense breast tissue, particularly for non-calcified lesion detection.  \nKeywords: breast; ultrasonography; mammography  \n1. Introduction  \nAdvancements in imaging technology have considerably improved breast cancer screening and diagnosis. With the increasing","cbCaisaoR94VCROw","https://ap.wps.com/l/cbCaisaoR94VCROw","pdf",12657881,16,"English","# Simple Summary\n# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What was the main objective of comparing MammouS-N with DBT?\",\"answer\":\"To compare visibility of breast cancer lesions between the standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and to determine factors affecting lesion visibility.\"},{\"question\":\"How was lesion visibility evaluated in the study?\",\"answer\":\"Two radiologists independently assigned visibility scores (0–5) to lesions corresponding to biopsy-confirmed breast cancers identified using magnetic resonance imaging.\"},{\"question\":\"What did the results show for non-calcified lesions?\",\"answer\":\"Noncalcified lesions that were obscured on DBT were better visualized on MammouS-N (p \\u003c 0.001) by both reviewers.\"}]","Comparison of Clinical Performance Between Digital Breast Tomosynthesis and MammouS-N | PDF",1790092850,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b97c0d9fdfdbc630715f9fcbf7f31b93.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/370408dbe92f84ecf405cd01f1deaaf7.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4115c88ffb7f581a53cf3c35f9f57b1e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed08e93e6f5134f456531bdd8b8d7775.webp",980,1385]